Related references
Note: Only part of the references are listed.Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epithelium
Jonathan L. Koff et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
DNA vector augments inflammation in epithelial cells via EGFR-dependent regulation of TLR4 and TLR2
Kenneth Liu et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
Inhibition of the EGF receptor blocks autocrine growth and increases the cytotoxic effects of doxorubicin in rat hepatoma cells Role of reactive oxygen species production and glutathione depletion
Conrad Ortiz et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma - Results of a multicenter phase 2 study
Amani Asnacios et al.
CANCER (2008)
Hepatocyte necrosis induced by oxidative stress and IL-1α release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis
Toshiharu Sakurai et al.
CANCER CELL (2008)
EGFR and VEGFR as potential target for biological therapies in HCC cells
Gianlulgi Giannelli et al.
CANCER LETTERS (2008)
Src and ADAM-17-Mediated Shedding of Transforming Growth Factor-α Is a Mechanism of Acute Resistance to TRAIL
Sandra Van Schaeybroeck et al.
CANCER RESEARCH (2008)
Clinical significance of pretreatment serum amphiregulin and transforming growth factor-α, and an epidermal growth factor receptor somatic mutation in patients with advanced non-squamous, non-small cell lung cancer
Katsuhiro Masago et al.
CANCER SCIENCE (2008)
Membrane-anchored growth factors, the epidermal growth factor family: Beyond receptor ligands
Shigeki Higashiyama et al.
CANCER SCIENCE (2008)
TACE/ADAM-17: A component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer
Nipun B. Merchant et al.
CLINICAL CANCER RESEARCH (2008)
NF-κB and cancer -: identifying targets and mechanisms
Willscott E. Naugler et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases
P-R. Burgel et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
CD95 ligand is a proliferative and antiapoptotic signa in quiescent hepatic stellate cells
Roland Reinehr et al.
GASTROENTEROLOGY (2008)
Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
Augusto Villanueva et al.
GASTROENTEROLOGY (2008)
Mechanisms of hepatic fibrogenesis
Scott L. Friedman
GASTROENTEROLOGY (2008)
The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis
Maria J. Perugorria et al.
HEPATOLOGY (2008)
Toll-like receptors and adaptor molecules in liver disease: Update
Ekihiro Seki et al.
HEPATOLOGY (2008)
Molecular targeted therapies in hepatocellular carcinoma
Josep M. Llovet et al.
HEPATOLOGY (2008)
Angiotensin II and epidermal growth factor receptor cross-talk mediated by a disintegrin and metalloprotease accelerates tumor cell proliferation of hepatocellular carcinoma cell lines
Hidenori Itabashi et al.
HEPATOLOGY RESEARCH (2008)
被撤回的出版物: Cyclooxygenase-2-derived Prostaglandin E2 Stimulates Id-1 Transcription (Retracted article. See vol. 295, pg. 296, 2020)
Kotha Subbaramaiah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Epidermal growth factor receptor signaling to Erk1/2 and STATs control the intensity of the epithelial inflammatory responses to rhinovirus infection
Kenneth Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family
H. Michael Shepard et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?
Olav A. Gressner et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
HB-EGF is a paracrine growth stimulator for early tumor prestages in inflammation-associated hepatocarcinogenesis
Sandra Sagmeister et al.
JOURNAL OF HEPATOLOGY (2008)
The epidermal growth factor receptor system in skin repair and inflammation
Saveria Pastore et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab
Shizhen Emily Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Drug therapy: EGFR antagonists in cancer treatment
Fortunato Ciardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Role of Toll-like receptors in gastrointestinal malignancies
M. Fukata et al.
ONCOGENE (2008)
EGFR-Targeted Therapeutics: Focus on SCCHN and NSCLC
Martin Sattler et al.
THESCIENTIFICWORLDJOURNAL (2008)
The wolf in sheep's clothing: the role of interieukin-6 in immunity, inflammation and cancer
Willscott E. Naugler et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer
Michael Hoepfner et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Expression of tumor necrosis factor-alpha converting enzyme in liver regeneration after partial hepatectomy
Xian-Ming Lin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Fas ligand-induced proinflammatory transcriptional responses in reconstructed human epidermis - Recruitment of the epidermal growth factor receptor and activation of map kinases
Sherry M. Farley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Mutations in the epidermal growth factor receptor gene and effects of EGFR-tyrosine kinase inhibitors on lung cancers
Takayuki Fukui et al.
GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2008)
Mitogenic signaling pathways induced by G protein-coupled receptors
Enrique Rozengurt
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors
Masayuki Fukata et al.
GASTROENTEROLOGY (2007)
Liver regeneration
George K. Michalopoulos
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
EGFR signaling is required for TGF-β1-Mediated COX-2 induction in human bronchial epithelial cells
Ming Liu et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
The EGF receptor is required for efficient liver regeneration
Anuradha Natarajan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Tackling EGFR signaling with TACE antagonists: a rational target for metalloprotease inhibitors in cancer
Paraic A. Kenny
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma
Melanie B. Thomas et al.
CANCER (2007)
Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma
Andrew X. Zhu et al.
CANCER (2007)
Molecular mechanisms of alcohol-mediated carcinogenesis
Helmut K. Seitz et al.
NATURE REVIEWS CANCER (2007)
Viral hepatitis and hepatocellular carcinoma
Carlos Romero Marrero et al.
ARCHIVES OF MEDICAL RESEARCH (2007)
Nuclear factor-κB and the hepatic inflammation-fibrosis-cancer axis
Ahmed M. Elsharkawy et al.
HEPATOLOGY (2007)
Activation of NADPH oxidase by transforming growth factor-β in hepatocytes mediates up-regulation of epidermal growth factor receptor ligands through a nuclear factor-κB-dependent mechanism
Miguel M. Murillo et al.
BIOCHEMICAL JOURNAL (2007)
Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production
Willscott E. Naugler et al.
SCIENCE (2007)
Erlotinib in non-small cell lung cancer treatment: Current status and future development
Cesare Gridelli et al.
ONCOLOGIST (2007)
Identification of a key pathway required for the sterile inflammatory response triggered by dying cells
Chun-Jen Chen et al.
NATURE MEDICINE (2007)
Macrophage-inflammatory protein-3α mediates epidermal growth factor receptor transactivation and ERK1/2 MAPK signaling in Caco-2 colonic epithelial cells via metalloproteinase-dependent release of amphiregulin
Sarah Keates et al.
JOURNAL OF IMMUNOLOGY (2007)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
TheEGF receptor family: spearheading a merger of signaling and therapeutics
Erez M. Bublil et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
Hepatitis B virus-induced oncogenesis
Joachim Lupberger et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Liver fibrosis: cellular mechanisms of progression and resolution
Neil C. Henderson et al.
CLINICAL SCIENCE (2007)
Survival and apoptosis: a dysregulated balance in liver cancer
Isabel Fabregat et al.
LIVER INTERNATIONAL (2007)
New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system
Carmen Berasain et al.
LIVER INTERNATIONAL (2007)
Resolving fibrosis in the diseased liver: Translating the scientific promise to the clinic
Ajay K. Muddu et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Cyclooxygenase-2 transactivates the epidermal growth factor receptor through specific E-prostanoid receptors and Tumor Necrosis Factor-alpha converting enzyme
Mazin A. Al-Salihi et al.
CELLULAR SIGNALLING (2007)
Mammalian toll-like receptors: from endogenous ligands to tissue regeneration
Z. Zhang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Impact of IGF-1R/EGFR cross-talks on hepatoma cell sensitivity to gefitinib
Christele Desbois-Mouthon et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
The role of cytokines in hepatocellular carcinoma
Anuradha Budhu et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Emerging paradigm: Toll-like receptor 4 - Sentinel for the detection of tissue damage
Kevin P. Mollen et al.
SHOCK (2006)
Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: Five-year follow-up of Southwest Oncology Group protocol S9911
Oliver W. Press et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells
Josefa Castillo et al.
CANCER RESEARCH (2006)
Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction
Chieh-Yu Lin et al.
FEBS LETTERS (2006)
Innate immunity gone awry: Linking microbial infections to chronic inflammation and cancer
M Karin et al.
CELL (2006)
Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin αv-mediated ADAM activity in hepatocellular carcinoma:: A novel functional target for gefitinib
M Matsuo et al.
CANCER SCIENCE (2006)
Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis
D. Kremsdorf et al.
ONCOGENE (2006)
Genetics of hepatocellular tumors
P. Laurent-Puig et al.
ONCOGENE (2006)
Comparative and integrative functional genomics of HCC
J-S Lee et al.
ONCOGENE (2006)
Viral hepatitis and liver cancer: the case of hepatitis C
M. Levrero
ONCOGENE (2006)
New therapies for hepatocellular carcinoma
M. A. Avila et al.
ONCOGENE (2006)
Dysregulation of growth factor signaling in human hepatocellular carcinoma
K. Breuhahn et al.
ONCOGENE (2006)
Hepatocellular carcinoma pathogenesis: from genes to environment
Paraskevi A. Farazi et al.
NATURE REVIEWS CANCER (2006)
Increases of amphiregulin and transforming growth factor-α in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers
N Ishikawa et al.
CANCER RESEARCH (2005)
Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach
A Lautrette et al.
NATURE MEDICINE (2005)
ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk
S Higashiyama et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
Erlotinib in previously treated non-small-cell lung cancer
FA Shepherd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Involvement of EGF receptor and c-Src in the survival signals induced by TGF-β1 in hepatocytes
MM Murillo et al.
ONCOGENE (2005)
Absence of epidermal growth factor receptor exon 18-21 mutation in hepatocellular carcinoma
MC Su et al.
CANCER LETTERS (2005)
Novel role for amphiregulin in protection from liver injury
C Berasain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Selective inhibition of TNF-α-induced activation of mitogen-activated protein kinases and metastatic activities by gefitinib
Y Ueno et al.
BRITISH JOURNAL OF CANCER (2005)
Hepatocellular carcinoma: Epidemiology risk factors, and screening
M Sherman
SEMINARS IN LIVER DISEASE (2005)
Epidermal growth factor-induced hepatocellular carcinoma: gene expression profiles in precursor lesions, early stage and solitary tumours
J Borlak et al.
ONCOGENE (2005)
Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis
E Schiffer et al.
HEPATOLOGY (2005)
Amphiregulin:: An early trigger of liver regeneration in mice
C Berasain et al.
GASTROENTEROLOGY (2005)
Heparin-binding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration
C Mitchell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cyclooxygenase-2 and epidermal growth factor receptor: Pharmacologic targets for chemoprevention
AJ Dannenberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands
U Sahin et al.
JOURNAL OF CELL BIOLOGY (2004)
Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion
B Schäfer et al.
ONCOGENE (2004)
ADAM17 mRNA expression and pathological features of hepatocellular carcinoma
Xiang Ding et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2004)
Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication
GM Argast et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The mechanism of cleavage of EGFR ligands induced by inflammatory cytokines in gastric cancer cells
S Tanida et al.
GASTROENTEROLOGY (2004)
Impaired hepatocyte regeneration in toll-like receptor 4 mutant mice
GL Su et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
Epiregulin is not essential for development of intestinal tumors but is required for protection from intestinal damage
D Lee et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Epidermal growth factor receptor: mechanisms of activation and signalling
RN Jorissen et al.
EXPERIMENTAL CELL RESEARCH (2003)
Liver fibrosis: Insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors
CQ Yang et al.
GASTROENTEROLOGY (2003)
Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma
MA Avila et al.
JOURNAL OF HEPATOLOGY (2000)
TNF-α regulates transforming growth factor-α expression in regenerating murine liver and isolated hepatocytes
RM Gallucci et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
